版本:
中国

BRIEF-Pfizer says in connection with Hospira acquisition, expects to incur costs of about $1 bln for up to 3-yr period post-acquisition

May 11 Pfizer Inc:

* Pfizer says in connection with Hospira acquisition, expects to incur costs of about $1 billion for up to three-year period post-acquisition-sec filing

* Pfizer says in early 2017, initiated new enterprise-wide cost reduction/productivity initiatives, which expect to complete by end of 2019

* Pfizer says 2017 cost reduction/productivity initiatives includes optimization of manufacturing plant network to support IH and EH products and pipelines

* Pfizer says during 2017-2019, expects to incur costs of about $750 million related to cost reduction initiatives Source text (bit.ly/2qxeUDQ) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐